{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T17:53:31Z","timestamp":1788630811025,"version":"build-2803163510"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["2010-11E61J12000210001"],"award-info":[{"award-number":["2010-11E61J12000210001"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","award":["GOA 15\/19 TBA"],"award-info":[{"award-number":["GOA 15\/19 TBA"]}],"id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.ejmech.2016.09.014","type":"journal-article","created":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T14:43:58Z","timestamp":1473432238000},"page":"773-781","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Identification of an indol-based derivative as potent and selective varicella zoster virus (VZV) inhibitor"],"prefix":"10.1016","volume":"124","author":[{"given":"Simona","family":"Musella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"di Sarno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Ciaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Sala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Spensiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Carmina","family":"Scala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3715-8680","authenticated-orcid":false,"given":"Carmine","family":"Ostacolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graciela","family":"Andrei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Balzarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Snoeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ettore","family":"Novellino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Campiglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Bertamino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel M.","family":"Gomez-Monterrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2016.09.014_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000060312","article-title":"Morphological and biological characteristics of varicella-zoster virus","volume":"3","author":"Rahaus","year":"1999","journal-title":"Contrib. Microbiol."},{"key":"10.1016\/j.ejmech.2016.09.014_bib2","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ncl.2008.03.011","article-title":"Varicella zoster virus infection: clinical features, molecular pathogenesis of disease, and latency","volume":"26","author":"Mueller","year":"2008","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.ejmech.2016.09.014_bib3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1586\/erv.10.30","article-title":"Herpes zoster and postherpetic neuralgia","volume":"9","author":"Johnson","year":"2010","journal-title":"Expert Rev. Vaccines"},{"issue":"Suppl 2","key":"10.1016\/j.ejmech.2016.09.014_bib4","first-page":"89A","article-title":"Varicella zoster virus and central nervous system syndromes","volume":"11","author":"Gilden","year":"2004","journal-title":"Herpes J. IHMF"},{"key":"10.1016\/j.ejmech.2016.09.014_bib5","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/rmv.362","article-title":"Varicella-zoster virus latency in human ganglia","volume":"12","author":"Kennedy","year":"2002","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.ejmech.2016.09.014_bib6","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S1474-4422(09)70134-6","article-title":"Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment","volume":"8","author":"Gilden","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejmech.2016.09.014_bib7","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJM200003023420906","article-title":"Neurologic complications of the reactivation of varicella-zoster virus","volume":"342","author":"Gilden","year":"2000","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2016.09.014_bib8","first-page":"1058","article-title":"Acute retinal necrosis: clinical features and therapy options","volume":"106","author":"Hillenkamp","year":"2009","journal-title":"Ophthalmol. Z. Dtsch. Ophthalmol. Ges."},{"key":"10.1016\/j.ejmech.2016.09.014_bib9","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/00000441-200106000-00003","article-title":"Zoster in patients infected with HIV: a review","volume":"321","author":"Vafai","year":"2001","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.ejmech.2016.09.014_bib10","series-title":"Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis","article-title":"Antiviral therapy of varicella-zoster virus infections","author":"Gnann","year":"2007"},{"key":"10.1016\/j.ejmech.2016.09.014_bib11","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2165\/00003495-199957020-00005","article-title":"Current pharmacological approaches to the therapy of varicella zoster virus infections: a guide to treatment","volume":"57","author":"Snoeck","year":"1999","journal-title":"Drugs"},{"issue":"Suppl 2","key":"10.1016\/j.ejmech.2016.09.014_bib12","first-page":"25","article-title":"Varicella zoster virus: natural history and current therapies of varicella and herpes zoster","volume":"14","author":"Breuer","year":"2007","journal-title":"Herpes J. IHMF"},{"key":"10.1016\/j.ejmech.2016.09.014_bib13","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1128\/CMR.16.4.569-596.2003","article-title":"Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections","volume":"16","author":"De Clercq","year":"2003","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2016.09.014_bib14","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/B978-0-12-405880-4.00004-4","article-title":"Advances in the treatment of varicella-zoster virus infections","volume":"67","author":"Andrei","year":"2013","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.ejmech.2016.09.014_bib15","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0925-4439(02)00091-1","article-title":"Chemotherapy of varicella-zoster virus by a novel class of highly specific anti-VZV bicyclic pyrimidine nucleosides","volume":"1587","author":"Balzarini","year":"2002","journal-title":"Biochim. Biophy. Acta"},{"key":"10.1016\/j.ejmech.2016.09.014_bib16","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1128\/AAC.01446-10","article-title":"Pharmacokinetics and safety of FV-100, a novel oral anti-herpes zoster nucleoside analogue, administered in single and multiple doses to healthy young adult and elderly adult volunteers","volume":"55","author":"Pentikis","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2016.09.014_bib17","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1128\/JVI.78.6.2853-2862.2004","article-title":"Roscovitine, a cyclin-dependent kinase inhibitor, prevents replication of varicella-zoster virus","volume":"78","author":"Taylor","year":"2004","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ejmech.2016.09.014_bib18","first-page":"88","article-title":"Resistance of herpesviruses to antiviral drugs: clinical impacts and molecular mechanisms","volume":"5","author":"Gilbert","year":"2002","journal-title":"Drug Resist. Updat. Rev. Comment. Antimicrob. Anticancer Chemother."},{"key":"10.1016\/j.ejmech.2016.09.014_bib19","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/jac\/37.3.403","article-title":"Antiviral resistance: mechanisms, clinical significance, and future implications","volume":"37","author":"Kimberlin","year":"1996","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2016.09.014_bib20","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1086\/515045","article-title":"Acyclovir-resistant herpes zoster in human immunodeficiency virus-infected patients: results of foscarnet therapy","volume":"27","author":"Breton","year":"1998","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"10.1016\/j.ejmech.2016.09.014_bib21","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nrmicro975","article-title":"Antivirals and antiviral strategies","volume":"2","author":"De Clercq","year":"2004","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2016.09.014_bib22","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/rmv.354","article-title":"Non-nucleoside inhibitors of herpesviruses","volume":"12","author":"Wathen","year":"2002","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.ejmech.2016.09.014_bib23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.antiviral.2004.10.003","article-title":"Inhibition of herpesvirus replication by a series of 4-oxo-dihydroquinolines with viral polymerase activity","volume":"65","author":"Hartline","year":"2005","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2016.09.014_bib24","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.1021\/jm050162b","article-title":"4-Oxo-4,7-dihydrothieno[2,3-b]pyridines as non-nucleoside inhibitors of human cytomegalovirus and related herpesvirus polymerases","volume":"48","author":"Schnute","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2016.09.014_bib25","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1093\/jac\/dkq198","article-title":"ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2","volume":"65","author":"Chono","year":"2010","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2016.09.014_bib26","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1016\/j.bmcl.2004.06.025","article-title":"Thiourea inhibitors of herpesviruses. Part 3: inhibitors of varicella zoster virus","volume":"14","author":"Di Grandi","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2016.09.014_bib27","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1128\/JVI.77.4.2349-2358.2003","article-title":"Identification of small molecule compounds that selectively inhibit varicella-zoster virus replication","volume":"77","author":"Visalli","year":"2003","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ejmech.2016.09.014_bib28","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1021\/jm8014662","article-title":"4-Benzyloxy-gamma-sultone derivatives: discovery of a novel family of non-nucleoside inhibitors of human cytomegalovirus and varicella zoster virus","volume":"52","author":"De Castro","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2016.09.014_bib29","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.cbpa.2010.02.018","article-title":"Privileged scaffolds for library design and drug discovery","volume":"14","author":"Welsch","year":"2010","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.ejmech.2016.09.014_bib30","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1016\/j.ejmech.2011.07.023","article-title":"Homology modeling in tandem with 3D-QSAR analyses: a computational approach to depict the agonist binding site of the human CB2 receptor","volume":"46","author":"Cichero","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.09.014_bib31","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s00894-010-0664-1","article-title":"CoMFA and CoMSIA analyses on 1,2,3,4-tetrahydropyrrolo[3,4-b]indole and benzimidazole derivatives as selective CB2 receptor agonists","volume":"16","author":"Cichero","year":"2010","journal-title":"J.\u00a0Mol. Model."},{"key":"10.1016\/j.ejmech.2016.09.014_bib32","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/jhet.349","article-title":"Biological importance of the indole nucleus in recent years: a comprehensive review","volume":"47","author":"Sharma","year":"2010","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2016.09.014_bib33","doi-asserted-by":"crossref","first-page":"4893","DOI":"10.1016\/j.bmc.2014.06.043","article-title":"Antiviral activity of benzimidazole derivatives. III. Novel anti-CVB-5, anti-RSV and anti-Sb-1 agents","volume":"22","author":"Tonelli","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.09.014_bib34","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2174\/092986708784049658","article-title":"Arbidol: a broad-spectrum antiviral compound that blocks viral fusion","volume":"15","author":"Boriskin","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.09.014_bib35","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/978-1-4757-9209-6_25","article-title":"Delavirdine mesylate, a potent non-nucleoside HIV-1 reverse transcriptase inhibitor","volume":"394","author":"Freimuth","year":"1996","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ejmech.2016.09.014_bib36","doi-asserted-by":"crossref","first-page":"993","DOI":"10.4161\/hv.23800","article-title":"Comparison of HDAC inhibitors in clinical development: effect on HIV production in latently infected cells and T-cell activation","volume":"9","author":"Rasmussen","year":"2013","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.ejmech.2016.09.014_bib37","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1021\/acs.jmedchem.5b01914","article-title":"Tryptamine-based derivatives as transient receptor potential melastatin type 8 (TRPM8) channel modulators","volume":"59","author":"Bertamino","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2016.09.014_bib38","series-title":"The Nuclear Overhauser Effect in Structural and Conformational Analysis","author":"Neuhaus","year":"2000"},{"key":"10.1016\/j.ejmech.2016.09.014_bib39","doi-asserted-by":"crossref","first-page":"5407","DOI":"10.1021\/jm400311n","article-title":"Synthesis, in\u00a0vitro, and in cell studies of a new series of [indoline-3,2\u2032-thiazolidine]-based p53 modulators","volume":"56","author":"Bertamino","year":"2013","journal-title":"J.\u00a0Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523416307401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523416307401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T04:48:42Z","timestamp":1718772522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523416307401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":39,"alternative-id":["S0223523416307401"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2016.09.014","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of an indol-based derivative as potent and selective varicella zoster virus (VZV) inhibitor","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2016.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}